Citation tools
"Beneficial Effects of PKF275-055, a Novel, Selective, Orally Bioavailable, Long-Acting Dipeptidyl Peptidase IV Inhibitor in Streptozotocin-Induced Diabetic Peripheral Neuropathy." Journal of Pharmacology and Experimental Therapeutics
340.1
(2012):
64-72.
Web. 06 July. 2020.